Among the molecular subtypes of breast cancer, ERα-positive breast tumors are a well-differentiated phenotype and are correlated with a better prognosis than ERα-negative breast tumors, which are extremely aggressive subtypes associated with a poor prognosis2,3. This evidence concerns the gene ESR1 and breast neoplasm.